Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Experimental Medicine|July 1, 1986
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expressionR S Accolla, M Jotterand-Bellomo, L Scarpellino, et al.Journal of Virology|October 6, 1997
Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus modelC Ardavin, F Luthi, M Andersson, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1987
Distinct mechanisms regulate MHC class II gene expression in B cells and macrophagesA Maffei, L Scarpellino, M Bernard, et al.Cell|August 13, 1993
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmissionW Held, G A Waanders, A N Shakhov, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controlsS Sartoris, M T Scupoli, L Scarpellino, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1988
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cellsF Latron, M Jotterand-Bellomo, A Maffei, et al.The Journal of Experimental Medicine|February 1, 1993
Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virusW Held, A N Shakhov, S Izui, et al.The Journal of Experimental Medicine|June 1, 1992
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7)W Held, A N Shakhov, G Waanders, et al.Nature|March 21, 1991
Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virusH Acha-Orbea, A N Shakhov, L Scarpellino, et al.Immunological Reviews|July 10, 1999
Interplays between mouse mammary tumor virus and the cellular and humoral immune responseH Acha-Orbea, D Finke, A Attinger, et al.Pageof 2